'Will see if interests are fully accommodated in RCEP'

Agencies
November 2, 2019

New Delhi, Nov 2: As he left for his visit to Bangkok, Prime Minister Narendra Modi on Saturday said India will consider whether its concerns and interests in trade in goods, services, and investments are being fully accommodated when he attends the meeting of the Regional Comprehensive Economic Partnership there.

Modi is travelling to Bangkok to participate in the 16th ASEAN-India Summit on November 3. He will also attend the 14th East Asia Summit and the 3rd Summit meeting of nations negotiating a Regional Comprehensive Economic Partnership (RCEP) agreement on November 4.

In a statement before his departure, the prime minister said during the visit, he will also hold bilateral meetings with a number of other world leaders present at Bangkok for related summit meetings.

"The ASEAN-related summits are an integral part of our diplomatic calendar and an important element in our Act East Policy. Our partnership with ASEAN is built around the key pillars of connectivity, capacity-building, commerce and culture," he said.

In January 2018, India had celebrated the 25th anniversary of its Dialogue Partnership with ASEAN in a special commemorative Summit in New Delhi where leaders of all 10 ASEAN states were chief guests at the Republic Day parade, he pointed out.

The prime minister said he will be reviewing with ASEAN partners, India cooperative activities, and examining plans for strengthening ASEAN and ASEAN-led mechanisms, enhancing connectivity (sea, land, air, digital and people-to-people), deepening economic partnerships, and expanding maritime cooperation.

The East Asia Summit (EAS) is today the leading element in the regional cooperative architecture, as a singular, leaders-led structure that is centred around ASEAN, and includes as members major countries in the region or with important interests in it, he said.

"We will be reviewing significant regional and global issues on the Agenda of the EAS, and examining the state of our current programmes and projects. I will also focus on our Indo-Pacific strategy, on which I am happy to note strong convergences with ASEAN partners and others at the EAS," Modi said.

At the RCEP Summit, India will take stock of the progress in RCEP negotiations, he said.

"We will consider all issues including whether India's concerns and interests in trade in goods, services, and investments are being fully accommodated, during this summit," the prime minister asserted.

Other elements of his visit include participating in a special leaders luncheon event on November 4, organised by the prime minister of Thailand, as chair of ASEAN on sustainability.

"I will also attend a reception organised by the Indian community in Thailand on November 2 (Saturday evening). People of Indian Origin and non-resident Indians have made significant contributions to Thailand and to the important relationship India shares with the Kingdom of Thailand," Modi said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 29,2020

New Delhi, Mar 29: The total confirmed coronavirus cases in India rose to 979, including 48 foreigners, according to the Ministry of Health and Family Welfare on Sunday.
There are 867 active cases of the disease as of Sunday, out of the total confirmed cases, while 87 persons have also been cured and discharged or migrated.
The number of deaths due to the infection rose to 25.
Maharashtra and Kerala, with 186 and 182 cases, have two of the highest number of positive cases in the country, with Maharashtra also recording six deaths due to the disease.
The Central government has taken many stringent measures to prevent the further spread of the disease with a 21-day nationwide lockdown being imposed.
The disease which originated from Wuhan, China has so far close to 6 lakh reported cases from around the world with more than 25 thousand deaths being reported due to it, as per World Health Organisation on March 28. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 15,2020

New Delhi, Jan 15: The mother of 23-year-old paramedic student, who was raped and brutally assaulted by six men in December 2012, on Tuesday said she knew that the curative petitions of the convicts will be rejected and is confident that they will be hanged on January 22.

Her remarks came after the Supreme Court on Tuesday refused to stay the execution of two of the four death row convicts in the 2012 Nirbhaya gang rape and murder case while dismissing their curative petitions against their conviction and capital punishment.

"The curative please had to be rejected. This was the third time they had gone to the Supreme Court. Whatever pleas they file, we are ready to face them and we will fight it out. We feel that they will be hanged on January 22. We want that to happen," Nirbhaya's mother told PTI over phone.

The four convicts -- Vinay Sharma (26), Mukesh Kumar (32), Akshay Kumar Singh (31) and Pawan Gupta (25) -- are to be hanged on January 22 at 7 am in Tihar jail as a Delhi court issued their death warrants on January 7.

Vinay and Mukesh had filed curative petitions on January 9.

Shortly after the apex court refused to stay the execution of two of them, Mukesh moved a mercy petition before President Ram Nath Kovind.

Mukesh also approached the Delhi High Court for quashing the death warrant. The high court is expected to take up his petition on Wednesday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.